Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study.
- Previous studies evaluated the association between proton pump inhibitor (PPI) use and subsequent fracture risk, but they showed ambiguous results. Therefore, the objective was to evaluate this association in a different study population. Our findings show that there is probably no causal relationship between PPI use and hip fracture risk.
- Publisher copy:
- Copyright date:
- PMCID: PMC3034906
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record